-
Mashup Score: 3Insightful Imaging for Geographic Atrophy - 9 month(s) ago
Advances in imaging technology have the potential to improve disease monitoring, allowing clinicians to tailor care to individual patients more effectively than ever.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet
-
Mashup Score: 8Peter Kaiser MD and Veeral Sheth MD MBA FACS FASRS discuss reducing injection burden and gene therapy - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
In our latest episode on the Retinal Physician Video Channel, Peter Kaiser, MD, and Veeral Sheth, MD, MBA, FACS, FASRS, discuss reducing injection burden and #genetherapy. https://t.co/LvoWcwzezG https://t.co/Q3LzSOcRjn
-
-
Mashup Score: 3Subspecialty News - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Kiora announced results showing that KIO-301 has the potential to meaningfully improve vision in patients with retinitis pigmentosa living with ultra-low vision or complete blindness. Read more in the Subspecialty News: https://t.co/rFkUVuL3s2 https://t.co/AKLiVm0e9i
-
-
Mashup Score: 4Subspecialty News - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Endogena Therapeutics announced that the #FDA has granted clearance for the company’s Investigational New Drug application for EA-2351, a novel compound for the treatment of #geographicatrophy. https://t.co/LvIP3QsXx6 https://t.co/5crcLOvN5x
-
-
Mashup Score: 8Subspecialty News - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
In a phase 3, multicenter study, XSB-001 demonstrated biosimilarity to reference ranibizumab for improvement of BCVA in patients with wet AMD. Read more in the Subspecialty News: https://t.co/cQBMtlBoCq #biosimilars #retinaldisease https://t.co/abncn6kOL2
-
-
Mashup Score: 12Subspecialty News - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
The FDA has agreed to the design and planned analysis of CoMpass, Aura Biosciences' phase 3 clinical trial of belzupacap sarotalocan (bel-sar; AU-011), for the first-line treatment of adult patients with early-stage #choroidalmelanoma. https://t.co/Nh27EV9ZAN https://t.co/oL33ShCf9b
-
-
Mashup Score: 11Subspecialty News - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Ocular Therapeutix has initiated its first pivotal clinical trial to evaluate OTX-TKI, an investigational hydrogel implant being evaluated for the treatment of wet AMD and other retinal diseases. Read more in the news: https://t.co/AXF7vZkqCN #clinicaltrials #retinaldisease https://t.co/qdntoiMK5h
-
-
Mashup Score: 27Subspecialty News - 9 month(s) ago
PentaVision is an independent company dedicated to eye care professionals. More about our magazines, newsletters, conferences, education and other services at pentavisionmedia.com.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
Ocugen announced that the first patient has been dosed in its phase 1/2 GARDian clinical trial for OCU410ST, a modifier gene therapy candidate being developed for Stargardt disease. https://t.co/M6caa0oQ8w https://t.co/4eCpL4uP4l
-
-
Mashup Score: 1Artificial Intelligence to Manage the AMD Burden - 9 month(s) ago
As the AI algorithms continue to be refined, they will likely be able to detect subtle changes in the eye that could go unnoticed by clinicians.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
A partnership between humans and technology has great potential for disease screening. Read more about how AI can help identify retinal disease: https://t.co/oWdJ6UezRw https://t.co/PvMh3uQwFQ
-
-
Mashup Score: 1Coding Q&A - 9 month(s) ago
There are important coding changes, as well as changes to Medicare reimbursement, that retina practices need to be aware of in the new year.
Source: retinalphysician.comCategories: General Medicine News, OphthalmologyTweet-
What’s new in #retina #coding for 2024? Revised E/M code descriptions and a new CPT code for suprachoroidal injections are among the changes. https://t.co/CIbsR1KkHO https://t.co/R28LVJnNCZ
-
Insightful Imaging for #GeographicAtrophy: Advances in imaging technology can improve monitoring but also introduce greater complexity to disease management. Read more: https://t.co/lL7YrOfRFg https://t.co/QDMAyPozzw